These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25964582)

  • 1. Profile of serum factors and disseminated tumor cells before and after radiofrequency ablation compared to resection of colorectal liver metastases - a pilot study.
    Hinz S; Tepel J; Röder C; Kalthoff H; Becker T
    Anticancer Res; 2015 May; 35(5):2961-7. PubMed ID: 25964582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
    Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
    Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell dissemination during curative surgery for colorectal liver metastases.
    Topal B; Aerts JL; Roskams T; Fieuws S; Van Pelt J; Vandekerckhove P; Penninckx F
    Eur J Surg Oncol; 2005 Jun; 31(5):506-11. PubMed ID: 15922887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated tumor cells in the bone marrow negatively influence survival after resection of colorectal liver metastases.
    Hinz S; Bockhorst J; Röder C; Egberts JH; Schafmayer C; Küchler T; Becker T; Kalthoff H
    Ann Surg Oncol; 2012 Aug; 19(8):2539-46. PubMed ID: 22395998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases.
    Hur H; Ko YT; Min BS; Kim KS; Choi JS; Sohn SK; Cho CH; Ko HK; Lee JT; Kim NK
    Am J Surg; 2009 Jun; 197(6):728-36. PubMed ID: 18789428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
    Abdalla EK; Vauthey JN; Ellis LM; Ellis V; Pollock R; Broglio KR; Hess K; Curley SA
    Ann Surg; 2004 Jun; 239(6):818-25; discussion 825-7. PubMed ID: 15166961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
    Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
    World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation of concomitant and recurrent pulmonary metastases after surgery for colorectal liver metastases.
    Chua TC; Al-Alem I; Zhao J; Glenn D; Liauw W; Morris DL
    Ann Surg Oncol; 2012 Jan; 19(1):75-81. PubMed ID: 21710327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis.
    Lee WS; Yun SH; Chun HK; Lee WY; Kim SJ; Choi SH; Heo JS; Joh JW; Choi D; Kim SH; Rhim H; Lim HK
    J Clin Gastroenterol; 2008 Sep; 42(8):945-9. PubMed ID: 18438208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
    de Jong KP; Hoedemakers RM; Fidler V; Bijzet J; Limburg PC; Peeters PM; de Vries EG; Slooff MJ
    Scand J Gastroenterol; 2004 Nov; 39(11):1141-8. PubMed ID: 15545174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.